Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14211-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14211-1-AP, RRID:AB_10638609
- Product name
- CD39/ENTPD1 antibody
- Antibody type
- Polyclonal
- Description
- CD39/ENTPD1 antibody (Cat. #14211-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Water intake accelerates ATP release from myofibroblast cells in rats: ATP-mediated podoplanin-dependent control for physiological function and immunity.
Single-cell Immune Landscape of Human Recurrent Miscarriage.
Identification of differential gene expression profile from peripheral blood cells of military pilots with hypertension by RNA sequencing analysis.
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.
Hayashi M, Watanabe-Asaka T, Nagashio S, Kaidoh M, Yokoyama Y, Maejima D, Kajihara R, Amari K, Arai N, Kawai Y, Ohhashi T
American journal of physiology. Gastrointestinal and liver physiology 2021 Jan 1;320(1):G54-G65
American journal of physiology. Gastrointestinal and liver physiology 2021 Jan 1;320(1):G54-G65
Single-cell Immune Landscape of Human Recurrent Miscarriage.
Wang F, Jia W, Fan M, Shao X, Li Z, Liu Y, Ma Y, Li YX, Li R, Tu Q, Wang YL
Genomics, proteomics & bioinformatics 2021 Apr;19(2):208-222
Genomics, proteomics & bioinformatics 2021 Apr;19(2):208-222
Identification of differential gene expression profile from peripheral blood cells of military pilots with hypertension by RNA sequencing analysis.
Zhao XC, Yang SH, Yan YQ, Zhang X, Zhang L, Jiao B, Jiang S, Yu ZB
BMC medical genomics 2018 Jul 11;11(1):59
BMC medical genomics 2018 Jul 11;11(1):59
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.
Costa F, Toscani D, Chillemi A, Quarona V, Bolzoni M, Marchica V, Vescovini R, Mancini C, Martella E, Campanini N, Schifano C, Bonomini S, Accardi F, Horenstein AL, Aversa F, Malavasi F, Giuliani N
Oncotarget 2017 Aug 22;8(34):56598-56611
Oncotarget 2017 Aug 22;8(34):56598-56611
No comments: Submit comment
No validations: Submit validation data